Zobrazeno 1 - 10
of 216
pro vyhledávání: '"John R Lurain"'
Autor:
Kenji Unno, Masanori Ono, Abigail D Winder, Kruti P Maniar, Ajit S Paintal, Yanni Yu, Jian-Jun Wei, John R Lurain, J Julie Kim
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e116064 (2014)
ObjectiveMost endometrial cancers are detected early and have a good prognosis, while some endometrial cancers are highly invasive, metastasize early, and respond suboptimally to therapy. Currently, appropriate model systems to study the aggressive n
Externí odkaz:
https://doaj.org/article/013d57a3cfe64d4bb55de21de84649d5
Publikováno v:
Gynecologic Oncology Reports, Vol 32, Iss , Pp - (2020)
Placental site trophoblastic tumor (PSTT) is a rare variant of gestational trophoblastic neoplasia (GTN) that is characterized by slow growth resulting in mostly uterine-confined disease, low human chorionic gonadotropin (hCG) levels, and resistance
Externí odkaz:
https://doaj.org/article/e59ce9cd3820462b84ce98a56125afd8
Autor:
Amishi Bajaj, Mahesh Gopalakrishnan, Matthew M. Harkenrider, John R. Lurain, William Small, Jr
Publikováno v:
Gynecologic Oncology Reports, Vol 23, Iss C, Pp 4-6 (2018)
The purpose of this article is to present a case of successful treatment of a patient with stage IVB small cell carcinoma of the cervix (SCCC) who was treated with concurrent chemoradiotherapy (CCRT) consisting of etoposide/cisplatin (EP) chemotherap
Externí odkaz:
https://doaj.org/article/a4fcdd5b51aa41e2b26bbf603b3ccb8e
Publikováno v:
Gynecologic Oncology Reports, Vol 21, Iss C, Pp 34-36 (2017)
Externí odkaz:
https://doaj.org/article/c0b8cc3dce604f4fafcff5a586f0b7d6
Autor:
Yang Xiang, Paradan K. Sekharan, Ross S. Berkowitz, Leon F.A.G. Massuger, Michael J. Seckl, Hextan Y.S. Ngan, François Golfier, John R. Lurain
Publikováno v:
International Journal of Gynecology & Obstetrics. 155:86-93
Gestational trophoblastic disease (GTD) arises from abnormal placenta and is composed of a spectrum of premalignant to malignant disorders. Changes in epidemiology of GTD have been noted in various countries. In addition to histology, molecular genet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2580186e3f41af5477a3138d635644da
https://doi.org/10.1002/ijgo.13877
https://doi.org/10.1002/ijgo.13877
Autor:
Robert L. Giuntoli, Christa Nagel, Nicole R. McMillian, Christina Chu, R. Kevin Reynolds, John R. Lurain, Andrea Mariani, David G. Mutch, Warner K. Huh, Steven W. Remmenga, Angela D. Motter, Hye Sook Chon, David K. Gaffney, Stefanie Ueda, Kristin A. Bradley, Susana M. Campos, Renata Urban, Todd Tillmanns, Christine M. Fisher, Emily Wyse, Rachel C. Sisodia, Peter J. Frederick, Larissa Nekhlyudov, David E. Cohn, Ernest S. Han, Nadeem R. Abu-Rustum, Amanda N. Fader, Sarah M. Bean, Catheryn M. Yashar, Shari Damast, Marta A. Crispens
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:660-666
The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and seco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8287582af9cdf65d1a9efdaa4af18a38
https://doi.org/10.6004/jnccn.2020.0027
https://doi.org/10.6004/jnccn.2020.0027
Autor:
Brannan B. Griffin, Brad J. Nakamura, Matthew Cowan, Jean Victoria Fischer, John R. Lurain, Anna E. Strohl
Publikováno v:
Gynecologic Oncology Reports, Vol 37, Iss, Pp 100802-(2021)
Gynecologic Oncology Reports
Gynecologic Oncology Reports
Highlights • ETT is a rare variant of GTN that is more chemoresistant than choriocarcinoma. • Approximately 25–35% of patients with ETT present with metastatic disease. • Chemotherapy for ETT should consist of an etoposide/platinum-based regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447b2ef3b061eb95c64e8e56de690138
http://www.sciencedirect.com/science/article/pii/S2352578921001065
http://www.sciencedirect.com/science/article/pii/S2352578921001065
Autor:
Valery Adorno-Cruz, Mathew Cowan, John R. Lurain, Masha Kocherginsky, Wendy M. Swetzig, Kaitlyn O'Shea, Emily Berry, Shohreh Shahabi, Deanna Taiym, Daniela Matei, Mario Javier Pineda, Valerie Nelson, Nikki L. Neubauer
Publikováno v:
Gynecologic oncology. 163(1)
Objective Tivozanib is a potent selective pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor with a long half-life. This study assessed its activity in patients with recurrent, platinum-resistant ovarian, fallopian tube or prim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b0711ef1e98f0d884479e093b1d1fa
https://pubmed.ncbi.nlm.nih.gov/34419285
https://pubmed.ncbi.nlm.nih.gov/34419285
Autor:
Nadeem R, Abu-Rustum, Catheryn M, Yashar, Sarah, Bean, Kristin, Bradley, Susana M, Campos, Hye Sook, Chon, Christina, Chu, David, Cohn, Marta Ann, Crispens, Shari, Damast, Christine M, Fisher, Peter, Frederick, David K, Gaffney, Robert, Giuntoli, Ernest, Han, Warner K, Huh, John R, Lurain Iii, Andrea, Mariani, David, Mutch, Christa, Nagel, Larissa, Nekhlyudov, Amanda Nickles, Fader, Steven W, Remmenga, R Kevin, Reynolds, Rachel, Sisodia, Todd, Tillmanns, Stefanie, Ueda, Renata, Urban, Emily, Wyse, Nicole R, McMillian, Angela D, Motter
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 18(6)
The NCCN Guidelines for Cervical Cancer provide recommendations for diagnostic workup, staging, and treatment of patients with the disease. These NCCN Guidelines Insights focus on recent updates to the guidelines, including changes to first- and seco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59c8b71abdca7e96a0cda077e79d3e30
https://pubmed.ncbi.nlm.nih.gov/32502976
https://pubmed.ncbi.nlm.nih.gov/32502976
Autor:
John R. Lurain, Emily Berry, Kruti P. Maniar, Abigail Winder, Anna V. Hoekstra, Janelle Sobecki-Rausch, Karen Novak
Publikováno v:
International Journal of Gynecological Cancer. 28:1117-1122
Objective Epithelioid trophoblastic tumor (ETT) is a rare variant of gestational trophoblastic neoplasia that develops from chorionic-type intermediate trophoblast, simulates carcinoma, presents years after a pregnancy event, is associated with low o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e77177b76d154e451d1608682448d3e4
https://doi.org/10.1097/igc.0000000000001278
https://doi.org/10.1097/igc.0000000000001278